Anwer Jaffri, M.D.
Infectious Disease Physician in Terre Haute, Indiana. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,292 in Infectious Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Anwer Jaffri, M.D. reported a CMS MIPS final score of 95/100 - above the 83.1 national average - and filed 14,057 Medicare Part D claims in 2023.
- 95/100
- MIPS score · +12 vs avg
- 14K
- Part D claims, 2023
- 70%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Anwer Jaffri, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
95 Top 21% higher than 79% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Anwer Jaffri, M.D. sits
This provider among infectious disease physician peers
Across the 2,276 infectious disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Anwer Jaffri, M.D. writes more Part D claims than 100% of them and scores higher on MIPS quality than 78% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one infectious disease physician peer from a representative sample of 60; the gold marker is Anwer Jaffri, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Anwer Jaffri, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Anwer Jaffri, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Infectious Disease Physician compares to other specialties among Indiana providers
Largest specialties in Indiana (% of in-state providers)
Infectious Disease Physician ranks #108 among Indiana's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Indiana provider total, by primary NUCC taxonomy. The highlighted bar is Infectious Disease Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Anwer Jaffri, M.D.'s 2023 MIPS final score plotted against the Infectious Disease Physician national average
- MIPS Final Score
- 95/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Infectious Disease Physician) - 95/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Infectious Disease Physician US NPIs
95/100 MIPS final score - 11.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Infectious Disease Physician. Quality dim: 80.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Anwer Jaffri, M.D. appears in the CMS NPPES registry as a Infectious Disease Physician provider holding M.D. credentials at 315 E DAVIS DR, Terre Haute, IN, 47802, with a listed phone of (812) 645-3472. NPI 1508974189 was issued on 08/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Jaffri most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 14,057 prescription claims written by this provider, covering 1,053 Medicare beneficiaries and totaling roughly $2.9 million in drug spend, split 30% brand-name and 70% generic by claim count, with an opioid prescribing rate of 3.3%. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95/100 for the 2023 performance year (Quality 80), compared with the national average of 83.1.
Infectious Disease Physician is a mid-sized specialty nationwide, with 8,292 enrolled providers across 54 states and an average of 816 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1508974189 |
|---|---|
| Specialty | Infectious Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/25/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Anwer Jaffri, M.D.'s current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Anwer Jaffri, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$11.8K
Largest payer
Gilead Sciences, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
30% brand-name claims vs 70% generic, on 14,057 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 14,226
- Total Day Supply
- 284,299
- Brand vs Generic
- 30% brand / 70% generic
- Brand Drug Cost
- $2.4M
- Generic Drug Cost
- $506K
- Opioid Claims
- 466 (3.3% rate)
- Antibiotic Claims
- 1,751
Patient Demographics
- Average Patient Age
- 71.0 years
- Avg HCC Risk Score
- 2.46
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 247, 65-74: 399, 75-84: 285, 85+: 122
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Anwer Jaffri, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
604 claims
- Furosemide
Furosemide
535 claims
- Eliquis
Eliquis
469 claims
- Doxycycline Hyclate
Doxycycline Hyclate
410 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
360 claims
- Atorvastatin Calcium
Atorvastatin Calcium
340 claims
- Sertraline Hcl
Sertraline Hcl
265 claims
- Pantoprazole Sodium
Pantoprazole Sodium
260 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 604 |
| Furosemide | 535 |
| Eliquis Apixaban | 469 |
| Doxycycline Hyclate | 410 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 360 |
| Atorvastatin Calcium | 340 |
| Sertraline Hcl | 265 |
| Pantoprazole Sodium | 260 |
| Potassium Chloride | 258 |
| Metoprolol Succinate | 245 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Infectious Disease Physician Overview
How Anwer Jaffri, M.D. fits within the Infectious Disease Physician landscape nationally.
Anwer Jaffri, M.D.'s 14,057 claims are above the specialty average of 816.
Nearby Infectious Disease Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Jaffri.
Compare Infectious Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Indiana medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Infectious Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is Anwer Jaffri, M.D.'s specialty? ▼
How much does Anwer Jaffri, M.D. prescribe under Medicare Part D? ▼
What is Anwer Jaffri, M.D.'s Medicare quality score? ▼
Where is Anwer Jaffri, M.D. located? ▼
What is Anwer Jaffri, M.D.'s NPI number? ▼
Does Anwer Jaffri, M.D. prescribe more brand-name or generic drugs? ▼
Does Anwer Jaffri, M.D. prescribe opioids? ▼
How many Infectious Disease Physician providers are there in the US? ▼
What drugs does Anwer Jaffri, M.D. prescribe most often? ▼
Does Anwer Jaffri, M.D. accept Medicare? ▼
How can I verify Anwer Jaffri, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology